As of 2024-12-14, the Relative Valuation of QuiaPEG Pharmaceuticals Holding AB (QUIA.ST) is (0.27) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 0.02 SEK, the upside of QuiaPEG Pharmaceuticals Holding AB based on Relative Valuation is -1587.3%.
The range of the Relative Valuation is (0.22) - (0.28) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.5x - 31.2x | 31.0x |
| Forward P/E multiples | 21.2x - 30.5x | 27.2x |
| Fair Price | (0.22) - (0.28) | (0.27) |
| Upside | -1302.1% - -1657.9% | -1587.3% |
| Date | P/E |
| 2024-11-20 | -3.89 |
| 2024-11-19 | -4.19 |
| 2024-11-18 | -4.73 |
| 2024-11-15 | -3.68 |
| 2024-11-14 | -3.66 |
| 2024-11-13 | -3.63 |
| 2024-11-12 | -4.62 |
| 2024-11-11 | -3.06 |
| 2024-11-08 | -3.14 |
| 2024-11-07 | -2.99 |
| 2024-11-06 | -3.12 |
| 2024-11-05 | -3.01 |
| 2024-11-04 | -3.43 |
| 2024-11-01 | -3.17 |
| 2024-10-31 | -3.47 |
| 2024-10-30 | -3.31 |
| 2024-10-29 | -3.23 |
| 2024-10-28 | -3.76 |
| 2024-10-25 | -2.69 |
| 2024-10-24 | -1.94 |
| 2024-10-23 | -1.94 |
| 2024-10-22 | -1.99 |
| 2024-10-21 | -2.04 |
| 2024-10-18 | -2.15 |
| 2024-10-17 | -2.29 |
| 2024-10-16 | -2.38 |
| 2024-10-15 | -2.40 |
| 2024-10-14 | -2.43 |
| 2024-10-11 | -2.33 |
| 2024-10-10 | -2.23 |
| 2024-10-09 | -2.21 |
| 2024-10-08 | -2.34 |
| 2024-10-07 | -2.35 |
| 2024-10-04 | -2.30 |
| 2024-10-03 | -2.18 |
| 2024-10-02 | -2.21 |
| 2024-10-01 | -2.15 |
| 2024-09-30 | -2.20 |
| 2024-09-27 | -2.24 |
| 2024-09-26 | -2.35 |
| 2024-09-25 | -2.26 |
| 2024-09-24 | -2.40 |
| 2024-09-23 | -2.47 |
| 2024-09-20 | -2.80 |
| 2024-09-19 | -2.86 |
| 2024-09-18 | -2.80 |
| 2024-09-17 | -2.64 |
| 2024-09-16 | -2.56 |
| 2024-09-13 | -2.62 |
| 2024-09-12 | -2.80 |